| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 455,094 | 1,387,112 | 1,100,780 | 1,514,683 | | Cost of Revenue |
-
| 1,080,744 | 818,573 | 1,102,356 | | | Gross Profit | 455,094 | 306,368 | 282,207 | 412,327 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 143,001 | 70,220 | 61,525 | 64,848 | | Non Recurring |
-
| 274,705 |
-
|
-
| | Others | 79,750 | 95,598 | 81,655 | 84,688 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 232,343 | (134,155) | 139,027 | 262,791 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 52,669 | (441,941) | 27,501 | 26,401 | | Earnings Before Interest And Taxes | 289,311 | (571,101) | 153,179 | 323,452 | | Interest Expense | 92,932 | 88,718 | 83,327 | 84,136 | | Income Before Tax | 196,379 | (659,819) | 69,852 | 239,316 | | Income Tax Expense | 15,361 | (568) | 22,319 | 18,928 | | Minority Interest | (310) | (8,347) | 1,031 | 4,585 | | | | Net Income From Continuing Ops | 180,708 | (659,251) | 47,533 | 220,388 | | | Non-recurring Events | | Discontinued Operations | 4,393 | (221,462) | 2,272 | 3,388 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 185,101 | (880,713) | 49,805 | 223,776 | | Preferred Stock And Other Adjustments | (6,369) | (6,352) | (6,333) | (6,384) | | | Net Income Applicable To Common Shares | $178,732 | ($887,065) | $43,472 | $217,392 |
|
0.45% Nasdaq 
0.20%
Income Statement
